Morgan Stanley has increased its investment rating on insurer Marsh & McLennan. From “equal weight” to “overweight.”
An analyst reported that the company’s stock price decline has been overdone given Marsh & McLennan’s variety of earnings mix, which includes profits from its fast-growing insurance brokerage segment.
According to the analyst, MMC is expected to generate $1.3 billion for free cash flow during the year.
Was this article valuable?
Here are more articles you may enjoy.
Baldwin Group to Buy CAC Group for About $1B in Cash and Stock 
Illinois Attorney General Announces $120M Settlement With Monsanto 
Acrisure CEO Greg Williams Makes $400M Commitment to Michigan State University 
Death of Teenager on Carnival Cruise Ship Ruled a Homicide 
